Skip to search formSkip to main contentSkip to account menu

Divalproex Sodium 125 MG Delayed Release Oral Capsule [Depakote]

Known as: Depakote Sprinkle 125 MG Delayed Release Oral Capsule, Depakote 125 MG Delayed Release Oral Sprinkle Capsule, DIVALPROEX SODIUM 125 mg ORAL CAPSULE [Depakote] 
National Institutes of Health

Related topics

Related topics

13 relations
Brilliant blue FCFD&C RED NO. 28Delayed Release Oral CapsuleDepakote

Broader (1)

Divalproex Sodium 125 MG Delayed Release Oral Capsule

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Depakote Sprinkle Capsules safely and effectively. See full prescribing information for Depakote Sprinkle Capsules. Depakote Sprinkle Capsules (divalproex sodium) Initial U.S Approval: 1989 WARNING…
  • 2008
  • Corpus ID: 16302945
Depakote Sprinkle Capsules (divalproex sodium) Initial U.S Approval: 1989 WARNING: LIFE THREATENING ADVERSE REACTIONS See full… 
2005
2005
Clinical Experiences High‐flux hemodialysis in the treatment of severe valproic acid overdose: A case report
Introduction: Hemoperfusion, with or without hemodialysis, has been used to treat patients suffering from severe valproic acid… 
1995
1995
Good mood surrounds Depakote® for bipolar disorders
&Low-dose valproate semisodium [divalproex sodium, Depakote®; Abbott] may be effective in stabilising symptoms in patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)